| Stage | ES | % of rev | EIX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.9B | 100.00% | $4.9B | 100.00% | EIX ×1.68 |
| Gross profit | $1.5B | 51.09% | $2.0B | 41.20% | ES +9.9pp |
| Operating income | $541M | 18.63% | $980M | 20.06% | EIX +1.4pp |
| Pre-tax income | $135M | 4.66% | $548M | 11.22% | EIX +6.6pp |
| Net income | $56M | 1.91% | $751M | 15.37% | EIX +13.5pp |
| Stage | ES | EIX | Gap · A − B |
|---|---|---|---|
| Revenue | $2.9B100.00% | $4.9B100.00% | EIX ×1.68 |
| Gross profit | 51.09%$1.5B | 41.20%$2.0B | ES +9.9pp |
| Operating income | 18.63%$541M | 20.06%$980M | EIX +1.4pp |
| Pre-tax income | 4.66%$135M | 11.22%$548M | EIX +6.6pp |
| Net income |
| 1.91%$56M |
| 15.37%$751M |
| EIX +13.5pp |
No shared counterparties.